Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With Periodontal Health and Stage III Periodontitis, Considering Both Smokers and Non-Smokers, Before and After Non-Surgical Periodontal Therapy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Erzurum, Turkey
- Ataturk University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The volunteers must not have any systemic diseases.
- The volunteers must be between 18 and 60 years of age.
- Control group: Periodontally healthy patients with no signs of periodontal disease and no history of smoking.
- Study Group I: Non-smoking patients with stage III periodontitis, evaluated based on clinical findings such as PD ≥ 5 mm and CAL ≥ 4 mm (with ≥ 30% of affected teeth), without radiographic evidence of bone loss and a history of smoking.
- Study Group II: Smoking patients with untreated stage III periodontitis, evaluated based on clinical findings such as PD ≥ 5 mm and CAL ≥ 4 mm (with ≥ 30% of affected teeth), with radiographic evidence of bone loss and a history of smoking for at least 10 cigarettes per day over the past 3 years.
Exclusion Criteria:
- The individual's unwillingness to participate in the study
- Being outside the specified age range
- Pregnant or breastfeeding patients
- Having a systemic disease
- Smoking in the past 10 years
- Having received periodontal treatment within the last 6 months
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Smokers with stage 3 periodontitis
|
non-surgical periodontal therapy
|
|
Non-smokers with stage 3 periodontitis
|
non-surgical periodontal therapy
|
|
Healthy Participant
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
assesment of Gremlin-1 pre-treatment
Time Frame: From enrollment to the end of treatment at 3 months
|
Measurement of Gremlin-1 levels using an ELISA kit from gingival crevicular fluid samples taken from patients before periodontitis treatment.
|
From enrollment to the end of treatment at 3 months
|
|
assesment of syndecan-4 pre treatment
Time Frame: From enrollment to the end of treatment at 3 months
|
Measurement of Syndecan-4- levels using an ELISA kit from gingival crevicular fluid samples taken from patients before periodontitis treatment.
|
From enrollment to the end of treatment at 3 months
|
|
Assesment of IL-1 Beta pre-treatment
Time Frame: From enrollment to the end of treatment at 3 months
|
Measurement of IL-1 Beta levels using an ELISA kit from gingival crevicular fluid samples taken from patients before periodontitis treatment.
|
From enrollment to the end of treatment at 3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024/01-16
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periodontitis (Stage 3)
-
NCT07549633Not yet recruitingPeriodontitis (Stage 3) | Periodontitis Stage IV
-
NCT07272980CompletedPeriodontitis (Stage 3) | Periodontitis Stage III
-
NCT07523841Active, not recruitingPeriodontitis | Periodontitis (Stage 3)
-
NCT07279896CompletedSmoking | Periodontitis (Stage 3)
-
NCT07472218Not yet recruitingPeriodontitis | Periodontal Pocket | Periodontitis (Stage 3)
-
NCT06933784CompletedPeriodontal Disease | Periodontitis (Stage 3) | Periodontitis Stage III
-
NCT07443410RecruitingPeriodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Stage IV
-
NCT07293962RecruitingPeriodontitis | Periodontitis Chronic Generalized Moderate | Periodontitis (Stage 3) | Periodontitis, Adult | Periodontitis Chronic Generalized Severe | Periodontitis, Chronic | Periodontitis Stage II | Periodontitis Chronic Localized Slight | Periodontitis Stage III
-
NCT06933797CompletedPeriodontal Disease | Periodontitis (Stage 3) | Periodontitis Stage III
-
NCT07090265Not yet recruiting
Clinical Trials on non-surgical periodontal therapy
-
NCT07090265Not yet recruiting
-
NCT07619040CompletedPeriodontitis | Periodontal Therapy | Probiotic | Oral Hygiene, Oral Health
-
NCT02379975CompletedRheumatoid Arthritis | Periodontitis
-
NCT05706675RecruitingInflammation | Periodontitis
-
NCT05297227Not yet recruitingPeriodontal Therapy | Non Responding Sites
-
NCT07316023RecruitingStage III Periodontitis
-
NCT05548933RecruitingBiomarkers | Hyperlipidemia | Serum | Periodontitis Chronic Generalized Severe | Gingival Crevicular Fluid | Non-surgical Periodontal Therapy
-
NCT05569525Active, not recruitingDiabetes Mellitus | Diabetes | Diabetes Mellitus, Type 1 | Periodontitis | Periodontal Diseases | Type 1 Diabetes